/
DMAA
$10.65+$0.02 (+0.19%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$258.3M
24M shares
52-week range
$10.17 – $10.65
100% from low
Sector
BLANK CHECKS
Exchange
NASDAQ
CS
Borrow rate
14.01%
Hard to borrow
Price (6 mo)
Loading chart…
Change+$0.69
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2024 | 2025 | |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of revenue | $0 | $0 |
| Gross profit | $0 | $0 |
| Gross margin | — | — |
| R&D | $0 | $0 |
| Operating income | −$479 | −$2.8M |
| EBITDA | −$279.8K | −$2.8M |
| Net income | −$479 | $5.9M |
| Net margin | — | — |
| EPS (diluted) | -0.06 | 0.19 |
Annual figures · source: Financial Modeling Prep
Peer comparison
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| DMAADrugs Made In America Acquisition Corp. Ordinary Shares | $10.65 | +0.19% | $359M | — |
| ALFCenturion Acquisition Corp. | $10.83 | -0.50% | $389M | — |
| LOKVLive Oak Acquisition Corp. V Class A Ordinary Shares | $11.52 | +0.00% | $331M | — |
| MLACMountain Lake Acquisition Corp. Class A | $0.98 | -16.24% | $30M | — |
| OYSEOyster Enterprises II Acquisition Corp |
Drugs Made In America Acquisition Corp. Ordinary Shares
Drugs Made In America Acquisition Corp is a blank check company.
- IPO / List date
- Feb 25, 2025
- HQ
- NEW YORK, NY
Held by traders on TradeandTell
No one on the platform currently holds DMAA.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in DMAA as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded DMAA yet.
